Oct. 26 at 6:23 PM
$TTOO
AI response your DD required...
Geopolitical and regulatory uncertainties
Strained international relations: Trade wars and geopolitical tensions, such as ongoing conflicts in Europe and the Middle East, have disrupted global supply chains and created higher operational uncertainties and costs. Tariffs, in particular, could increase the costs of devices, jeopardizing profitability for both manufacturers and hospitals.
How the diagnostics sector is responding
Despite the challenges, the medical diagnostics sector has seen continued M&A activity, though with different characteristics:
Resilience and stabilization: Reports from late 2024 and mid-2025 show that the broader healthcare M&A market began to stabilize as economic uncertainties eased, with deal volume remaining steady or slightly increasing, particularly in life sciences and digital health.